[1] 李情情,岳倩文,钱亚云,等.儿童系统性红斑狼疮合并感染的临床特征及危险因素分析[J].西部医学, 2024, 36(3): 422-426,432.
[2] 刘丽,刘瑛琦,郜赵伟.系统性红斑狼疮与肺动脉高压患者外周血共有差异表达基因研究[J].国际免疫学杂志,2024, 47(2):129-135.
[3] Balomenos D. Cell Cycle
Regulation and Systemic Lupus Erythematosus[J]. Systemic Lupus Erythematosus, 2011, 11,1.
[4] 胡冬,庄利东,陈刚,等.SLE患者慢性肾病的发生与血清抗核抗体荧光核型模式的相关性分析[J]. 国际检验医学杂志,2023,44(21):2636-2642.
[5] 万志杰,王航,杜志鹏,等.基于TCGA数据库的肺癌和结直肠癌放疗后差异基因筛选、功能及通路研究[J]. 同济大学学报(医学版),2022,43(4):467-473.
[6] 徐文飞,明春玉,梅其杰,等.基于GEO数据库对骨关节炎半月板差异基因的筛选及生物信息学分析[J].中国医药导报,2023,20(32):11-16.
[7] 颜南,王润新,王正东,等.胃癌GEO芯片结合TCGA数据差异基因筛选、功能及通路研究[J].中国医科大学学报,2022,51(4):329-335.
[8] 董洋,王丽姣,曹慧霞,等.系统性红斑狼疮疾病活动评分评估系统性红斑狼疮疾病活动的临床价值研究[J].中华风湿病学杂志,2023,27(2):91-95.
[9] 陈凝,龙现明,林滇恬,等.系统性红斑狼疮患者外周血自然杀伤T细胞免疫球蛋白样转录物2水平变化和临床意义[J].中华风湿病学杂志,2024,28(4):232-236.
[10] Besliu A, Banica L, Matache C, et al. Systemic lupus erythematosus: the
involvement of PI3K/Akt/mTOR pathway in cellular cycle and in early apoptosis[J].Joint Bone Spine, 2008,75(2):246.
[11] Guo J, Wu Y, Du J, et al. Deregulation of
UBE2C-mediated autophagy repression aggravates NSCLC progression[J].Oncogenesis,2018,7(6):49.
[12] Xiang C, Yan HC. Ubiquitin conjugating enzyme E2 C (UBE2C) may play a dual role involved in the
progression of thyroid carcinoma[J].Cell Death Discov,2022,8(1):130.
[13] Broderick R, Nasheuer HP. Regulation of CDC45 in the cell cycle and after DNA
damage[J].Biochem Soc Trans,2009,37(Pt 4):926-930.
[14] He Z, Wang X, Yang Z, et al. Expression and prognosis of CDC45 in cervical cancer based
on the GEO database[J].PeerJ,2021,9:e12114.
[15] Liu K, Zheng M, Lu R, et al. The role of CDC25C in cell cycle regulation and clinical
cancer therapy: a systematic review[J].Cancer Cell Int,2020,20:213.
[16] Shen T, Huang S. The role of CDC25A in the regulation of cell proliferation
and apoptosis [J].Anticancer Agents Med
Chem,2012,12(6):631-639.
[17] Han L, Li F. Origin recognition complex subunit 1 (ORC1) augments malignant behaviors of lung
adenocarcinoma cells via targeting Wnt signaling[J].Bioengineered,2022,13(5):13520-13533.
[18] Xiao YX, Yang WX. KIFC1: a promising
chemotherapy target for cancer treatment?[J].Oncotarget,2016,7(30):48656-48670.
[19] Yu QY, Liu H, Liao XH. CENPA regulates tumor stemness in
lung adenocarcinoma[J].AGING,2022,14(3):5537-5553.
[20] Russo K, Hoch S, Dima C, et al. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemiclupus erythematosus, and rheumatoid
arthritis[J].J Rheumatol, 2020,27(1):142-148.
|